BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2585739)

  • 1. [Calcium channel blockers and cerebral circulation].
    Uematsu D; Fukuuchi Y
    Nihon Rinsho; 1989 Aug; 47(8):1770-5. PubMed ID: 2585739
    [No Abstract]   [Full Text] [Related]  

  • 2. [Agents to improve cerebrovascular circulation and cerebral metabolism--calcium antagonists].
    Kyoi K; Utsumi S
    Nihon Rinsho; 1985 Feb; 43(2):368-71. PubMed ID: 3889411
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical application of calcium antagonists in the treatment of cerebral infarction].
    Komatsumoto S; Gotoh F
    Nihon Rinsho; 1989 Aug; 47(8):1837-41. PubMed ID: 2585748
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cerebral protective effects by continuous administration of a calcium antagonist after canine global brain ischemia--change in cerebral blood flow and metabolism].
    Ono K; Iwatsuki N; Obara S; Hashimoto Y
    Masui; 1988 Jan; 37(1):23-8. PubMed ID: 3367498
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thresholds in cerebral ischemia: variability and lability].
    Derouesné C
    Agressologie; 1986 Jun; 27(7):587-90. PubMed ID: 3777351
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cerebral circulation and calcium antagonists].
    Uematsu D; Fukuuchi Y
    No To Shinkei; 1990 Jan; 42(1):17-31. PubMed ID: 2186763
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of calcium antagonist nimodipine and induced hypertension on cerebral vessel reactivities, cerebral blood flow, cerebral edema and infarction in cats with one hour middle-cerebral-artery occlusion].
    Sakaki T; Ishida T; Sasaoka Y; Thunoda S; Utsumi S
    No Shinkei Geka; 1990 May; 18(5):423-30. PubMed ID: 2385317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
    Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
    Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the calcium antagonist nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Shiino A; Matsuda M; Susumu T; Handa J
    Surg Neurol; 1991 Feb; 35(2):105-10. PubMed ID: 1990476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Calcium antagonists and cerebrovascular circulation].
    De Gregorio C
    Clin Ter; 1987 Oct; 123(1):41-50. PubMed ID: 2972466
    [No Abstract]   [Full Text] [Related]  

  • 11. [Calcium antagonists and cerebral circulation].
    Bes A; Géraud G; Fabre N
    Rev Prat; 1988 Nov; 38(27):1983-5. PubMed ID: 3206150
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes in the blood circulation in the middle cerebral and common carotid arteries of rats under the influence of flunarizine].
    Semkina GA; Matsievskiĭ DD; Mirzoian RS
    Eksp Klin Farmakol; 1997; 60(1):28-31. PubMed ID: 9162277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S; Trabucchi M; Battaini F; Magnoni MS; Paoletti R
    Minerva Med; 1986 Jun; 77(24):1053-8. PubMed ID: 3725133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium entry blockers in cerebral resuscitation.
    Sakabe T
    Magnesium; 1989; 8(5-6):238-52. PubMed ID: 2693845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrovascular selectivity and vasospasmolytic action of the novel calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]oxepin-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate in isolated cerebral arteries of the rabbit and dog.
    Minato H; Hashizume M; Masuda Y; Fujitani B; Hosoki K
    Arzneimittelforschung; 1997 Apr; 47(4):339-46. PubMed ID: 9150852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular effects of the calcium antagonistic dihydropyridine derivative nimodipine in animal experiments.
    Kazda S; Garthoff B; Krause HP; Schlossmann K
    Arzneimittelforschung; 1982; 32(4):331-8. PubMed ID: 7201801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of cinnarizine and alvityl on cerebral blood flow and high nervous activity in chronic cerebral ischemia model].
    Gromova OA; Grishina TR; Sadin AV; Nikonov AA; Nazarenko OA; Zhidomorov NIu; Vatsuro AA; Borzunov MP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(1):52-3. PubMed ID: 14870694
    [No Abstract]   [Full Text] [Related]  

  • 18. [Regional brain calcium change in rabbit cerebral ischemia].
    Gu W; Yang Q; Ou Y
    Zhonghua Yi Xue Za Zhi; 1996 Oct; 76(10):771-3. PubMed ID: 9275522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats.
    Tanaka Y; Omura T; Fukasawa M; Horiuchi N; Miyata N; Minagawa T; Yoshida S; Nakaike S
    Neurosci Res; 2007 Dec; 59(4):475-80. PubMed ID: 17933409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemistry of intraischemic and postischemic brain injury (author's transl)].
    Kogure K
    No Shinkei Geka; 1980 Apr; 8(4):313-27. PubMed ID: 6991968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.